Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews
Meta-review (57 reviews) found most, except Cochrane, were lacking in quality and cannot provide a basis for decision-making. No review examined effects of a particular cannabinoid, at particular dose/administration, for a particular condition nor analgesic outcome.
Source:
Cochrane Database of Systematic Reviews